Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

This publication has 79 references indexed in Scilit:

• The Role of Iron in Parkinson Disease and 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Toxicity
  IUBMB Life, 1999
• The Role of Iron in Neurodegeneration
  Drugs & Aging, 1999
• Excessive iron accumulation in the brain: A possible potential risk of neurodegeneration in Parkinson's disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
• Role of H and L Subunits in Mouse Ferritin
  Journal of Biological Chemistry, 1996
• Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain
  Journal of Comparative Neurology, 1993
• MPTP-induced parkinsonism as a model for Parkinson's disease
  Acta Neurologica Scandinavica, 1989
• Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
• INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN
  The Lancet, 1987
• Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment
  Neuroscience Letters, 1986
• Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.
  Journal of Epidemiology and Community Health, 1975